Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: DiaGenic CEO Christensen Resigns; NanoString Taps Beecham as SVP of R&D


DiaGenic said this week that CEO Erik Christensen has resigned.

Christensen will "continue to provide consultative support to the company on partner interactions, licensing and other business activities," DiaGenic said in a statement.

Henrik Lund, chairman of the company's board, will serve as CEO until a replacement for Christensen is found. Ingrid Wiik, deputy chairman of the board, will act as chairman until the company's annual general meeting on June 5.

Christensen has been CEO of DiaGenic since 2007.

NanoString Technologies has appointed Joseph Beechem as senior vice president of research and development.

Beechem joins the company from Life Technologies, where he was most recently vice president; head of advanced sequencing; and head of global sequencing chemistry, biochemistry, and biophysics. Prior to that, he was chief technology officer of Life Technologies, chief scientific officer at Invitrogen (now part of Life Tech), and director of biosciences at Molecular Probes.

Prior to joining industry, Beechem was an associate professor at Vanderbilt University for 11 years. He holds a BS in chemistry and biology from Northern Kentucky University and a PhD in biophysics from Johns Hopkins University.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.